Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.5 (
RNase P
)
1,348
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A novel transcription system was constructed that allows trimming of 3' termini of RNA transcripts in E. coli by endogenous
RNase P
. Here, the sequence of tRNASer from E. coli
fused
downstream of the target sequence directs posttranscriptional cleavage 3' of the target sequence. As a first-target MNV11(+), a self-replicating RNA from the QB system was subjected to transcription in vivo. Northern blotting experiments revealed that the primary transcript was indeed successfully processed to an RNA of expected length. The RNA released proved to function as an active template for QB replicase. Moreover, E. coli cells producing these short-chain replicator molecules no longer supported multiplication of QB phages upon infection. Since the novel transcript-trimming system utilizes the endogenous
RNase P
activity and does not depend on any particular 3'-terminal RNA sequence of target molecules, it may have wide applications for a number of different targets in prokaryotes. Further applications, including those in eukaryotes, are discussed.
...
PMID:Novel vector for generating RNAs with defined 3' ends and its use in antiviral strategies. 945 63
The accurate function of C5 protein, the protein component of Escherichia coli
RNase P
, is uncertain in vivo. A controllable expression system for C5 protein was constructed which can be used to investigate effects of C5 protein on various cellular functions including biosynthesis of
RNase P
in vivo. The semisynthetic rnpA gene encoding C5 protein was
fused
to the tac promoter of the pKK223-3 expression vector. This tac promoter expression system produced a high level of C5 protein upon induction with isopropyl-beta-D-thiogalacto-pyranoside. When the overexpressed C5 protein was purified and used for reconstitution of
RNase P
, the reconstituted enzyme was active. The N-terminal amino acid of the overexpressed C5 protein was leucine specified by the second codon of the rnpA gene. The more controllable expression system was constructed by introducing the lacIq gene into the vector sequence itself.
...
PMID:Expression of C5 protein, the protein component of Escherichia coli RNase P, from the tac promoter. 957 38
Rpm2p, a protein subunit of yeast mitochondrial
RNase P
, has another function that is essential in cells lacking the wild-type mitochondrial genome. This function does not require the mitochondrial leader sequence and appears to affect transcription of nuclear genes. Rpm2p expressed as a fusion protein with green fluorescent protein localizes to the nucleus and activates transcription from promoters containing lexA-binding sites when
fused
to a heterologous DNA binding domain, lexA. The transcriptional activation region of Rpm2p contains two leucine zippers that are required for transcriptional activation and are conserved in the distantly related yeast Candida glabrata. The presence of a mitochondrial leader sequence does not prevent a portion of Rpm2p from locating to the nucleus, and several observations suggest that the nuclear location and transcriptional activation ability of Rpm2p are physiologically significant. The ability of RPM2 alleles to suppress tom40-3, a temperature-sensitive mutant of a component of the mitochondrial import apparatus, correlates with their ability to transactivate the reporter genes with lexA-binding sites. In cells lacking mitochondrial DNA, Rpm2p influences the levels of TOM40, TOM6, TOM20, TOM22, and TOM37 mRNAs, which encode components of the mitochondrial import apparatus, but not that of TOM70 mRNA. It also affects HSP60 and HSP10 mRNAs that encode essential mitochondrial chaperones. Rpm2p also increases the level of Tom40p, as well as Hsp60p, but not Atp2p, suggesting that some, but not all, nucleus-encoded mitochondrial components are affected.
...
PMID:Rpm2p, a component of yeast mitochondrial RNase P, acts as a transcriptional activator in the nucleus. 1602 91
Ribonucleoprotein complexes (RNPs) play crucial roles in a wide range of biological processes. Here, we describe experimental approaches to the UV crosslinking-based identification of protein-binding sites on RNA, using multicomponent Saccharomyces cerevisiae RNPs of the
RNase P
/MRP family as an example. To identify the binding sites of a protein component of interest, a hexahistidine affinity tag was
fused
to that protein. Then
RNase P
/MRP RNPs were purified from yeast cells that had expressed the protein component of interest with the
fused
tag, subjected to UV crosslinking, and disassembled to separate the non-covalently-bound components. The protein component of interest was isolated under denaturing conditions using the hexahistidine tag as a purification handle. Provided that the isolated protein formed UV-induced crosslinks with the RNA component of the studied RNP, the isolation of the protein resulted in the co-isolation of the covalently bound RNP RNA. The isolated protein was enzymatically degraded, and the UV crosslinked RNA was purified. The locations of the crosslinks formed between the protein component of interest and the RNP RNA were identified by primer extension with a reverse transcriptase followed by gel electrophoresis; this procedure was repeated for all of the protein components of RNases P/MRP.
...
PMID:Applying UV crosslinking to study RNA-protein interactions in multicomponent ribonucleoprotein complexes. 2413 5